Ensure only Covaxin is given to 15-18 group: Bharat Biotech January 18, 2022 by Indo-Asian News Service
DCGI to review applications of Bharat Biotech, SII for full market approval to Covaxin, Covishield today January 14, 2022 by Indo-Asian News Service
Administer only Covaxin to 15-18 age group: Bharat Biotech to healthcare workers January 8, 2022 by Asian News International
DGCI approves for phase III trial of Bharat Biotech intranasal vaccine as booster January 5, 2022 by Indo-Asian News Service
Bharat Biotech seeks approval for Phase 3 trials of intranasal vaccine December 21, 2021 by Indo-Asian News Service
Opened Covaxin vial can be stored for 28 days, says Bharat Biotech December 20, 2021 by Indo-Asian News Service
Covaxin found to be 77.8% effective against COVID-19: Lancet November 12, 2021 by Asian News International
After Australia, 5 more countries recognise India’s Covaxin November 1, 2021 by Indo-Asian News Service
WHO to decide on Bharat Biotech’s Covaxin emergency usage in October September 30, 2021 by Asian News International
Bharat Biotech completes phase 2/3 trials of Covaxin for children September 21, 2021 by Press Trust of India
COVID-19: WHO approval for Covaxin expected this week: Sources September 13, 2021 by Asian News International
IVI, Bharat Biotech begin phase II/III clinical trial of Chikungunya vaccine August 25, 2021 by Asian News International
Centre approves Bharat Biotech production facility at Gujarat August 10, 2021 by Indo-Asian News Service
Every batch of Covaxin subjected to over 200 quality control tests: Bharat Biotech August 6, 2021 by Asian News International
Covaxin receives Good Manufacturing Practice certificate from Hungaria August 5, 2021 by Asian News International
VP seeks to expedite development of COVID vaccine for children July 31, 2021 by Indo-Asian News Service
